APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Polyglycolic Acid (PGA)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Polyglycolic Acid (PGA) Market Outlook and Growth Opportunities 2026

Report ID 173306740422 December 2025196 pages

Choose your research edition.

Industry ResearchMedical Polyglycolic Acid (PGA) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Polyglycolic Acid (PGA) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Medical Polyglycolic Acid (PGA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Polyglycolic Acid (PGA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Polyglycolic Acid (PGA) Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Medical Polyglycolic Acid (PGA) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Polyglycolic Acid (PGA) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Polyglycolic Acid (PGA) market include Sinopec, Yulin Energy Group, Evonik, Shanghai Pujing Chemical, Huayang Medical, Danhua Technology, Shenzhen Polymtek Biomaterial and Kureha, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Polyglycolic Acid (PGA) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Polyglycolic Acid (PGA) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Polyglycolic Acid (PGA) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Polyglycolic Acid (PGA) market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Polyglycolic Acid (PGA) Segment by Company

Sinopec

Yulin Energy Group

Evonik

Shanghai Pujing Chemical

Huayang Medical

Danhua Technology

Shenzhen Polymtek Biomaterial

Kureha

Medical Polyglycolic Acid (PGA) Segment by Type

Copolymer

Homopolymer

Block Copolymers

Medical Polyglycolic Acid (PGA) Segment by Application

Tissue Engineering Scaffold

Medical Suture

Drug Controlled Release Carrier

Fracture Fixation Material

Stitched Reinforcement Material

Medical Polyglycolic Acid (PGA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Polyglycolic Acid (PGA) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Polyglycolic Acid (PGA) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Polyglycolic Acid (PGA) significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Polyglycolic Acid (PGA) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polyglycolic Acid (PGA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Polyglycolic Acid (PGA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polyglycolic Acid (PGA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Polyglycolic Acid (PGA) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Polyglycolic Acid (PGA) industry.

Chapter 3: Detailed analysis of Medical Polyglycolic Acid (PGA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Polyglycolic Acid (PGA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Polyglycolic Acid (PGA) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Polyglycolic Acid (PGA) Industry Trends Table 2. Medical Polyglycolic Acid (PGA) Industry Drivers Table 3. Medical Polyglycolic Acid (PGA) Industry Opportunities and Challenges Table 4. Medical Polyglycolic Acid (PGA) Industry Restraints Table 5. Global Medical Polyglycolic Acid (PGA) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Polyglycolic Acid (PGA) Revenue Share by Company (2021-2026) Table 7. Global Medical Polyglycolic Acid (PGA) Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Company (2021-2026) Table 9. Global Medical Polyglycolic Acid (PGA) Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Medical Polyglycolic Acid (PGA) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Polyglycolic Acid (PGA) Key Company Manufacturing Base & Headquarters Table 12. Global Medical Polyglycolic Acid (PGA) Company, Product Type & Application Table 13. Global Medical Polyglycolic Acid (PGA) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Polyglycolic Acid (PGA) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Copolymer Table 18. Significant Companies of Homopolymer Table 19. Significant Companies of Block Copolymers Table 20. Global Medical Polyglycolic Acid (PGA) Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Medical Polyglycolic Acid (PGA) Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Medical Polyglycolic Acid (PGA) Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Type (2021-2026) Table 24. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Type (2027-2032) Table 25. Global Medical Polyglycolic Acid (PGA) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Polyglycolic Acid (PGA) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Medical Polyglycolic Acid (PGA) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Type (2021-2026) Table 29. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Tissue Engineering Scaffold Table 31. Significant Companies of Medical Suture Table 32. Significant Companies of Drug Controlled Release Carrier Table 33. Significant Companies of Fracture Fixation Material Table 34. Significant Companies of Stitched Reinforcement Material Table 35. Global Medical Polyglycolic Acid (PGA) Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Medical Polyglycolic Acid (PGA) Sales Volume by Application (2021-2026) & (Tons) Table 37. Global Medical Polyglycolic Acid (PGA) Sales Volume by Application (2027-2032) & (Tons) Table 38. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Application (2021-2026) Table 39. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Application (2027-2032) Table 40. Global Medical Polyglycolic Acid (PGA) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Medical Polyglycolic Acid (PGA) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Medical Polyglycolic Acid (PGA) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Application (2021-2026) Table 44. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Application (2027-2032) Table 45. Global Medical Polyglycolic Acid (PGA) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Medical Polyglycolic Acid (PGA) Sales by Region (2021-2026) & (Tons) Table 47. Global Medical Polyglycolic Acid (PGA) Sales Market Share by Region (2021-2026) Table 48. Global Medical Polyglycolic Acid (PGA) Sales by Region (2027-2032) & (Tons) Table 49. Global Medical Polyglycolic Acid (PGA) Sales Market Share by Region (2027-2032) Table 50. Global Medical Polyglycolic Acid (PGA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Medical Polyglycolic Acid (PGA) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Region (2021-2026) Table 53. Global Medical Polyglycolic Acid (PGA) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Region (2027-2032) Table 55. Global Medical Polyglycolic Acid (PGA) Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Medical Polyglycolic Acid (PGA) Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Medical Polyglycolic Acid (PGA) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Global Medical Polyglycolic Acid (PGA) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Medical Polyglycolic Acid (PGA) Sales by Country (2021-2026) & (Tons) Table 60. Global Medical Polyglycolic Acid (PGA) Sales Market Share by Country (2021-2026) Table 61. Global Medical Polyglycolic Acid (PGA) Sales by Country (2027-2032) & (Tons) Table 62. Global Medical Polyglycolic Acid (PGA) Sales Market Share by Country (2027-2032) Table 63. Global Medical Polyglycolic Acid (PGA) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Medical Polyglycolic Acid (PGA) Sales Value Market Share by Country (2021-2026) Table 65. Global Medical Polyglycolic Acid (PGA) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Medical Polyglycolic Acid (PGA) Sales Value Market Share by Country (2027-2032) Table 67. Sinopec Company Information Table 68. Sinopec Business Overview Table 69. Sinopec Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Sinopec Medical Polyglycolic Acid (PGA) Product Portfolio Table 71. Sinopec Recent Development Table 72. Yulin Energy Group Company Information Table 73. Yulin Energy Group Business Overview Table 74. Yulin Energy Group Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Yulin Energy Group Medical Polyglycolic Acid (PGA) Product Portfolio Table 76. Yulin Energy Group Recent Development Table 77. Evonik Company Information Table 78. Evonik Business Overview Table 79. Evonik Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Evonik Medical Polyglycolic Acid (PGA) Product Portfolio Table 81. Evonik Recent Development Table 82. Shanghai Pujing Chemical Company Information Table 83. Shanghai Pujing Chemical Business Overview Table 84. Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Product Portfolio Table 86. Shanghai Pujing Chemical Recent Development Table 87. Huayang Medical Company Information Table 88. Huayang Medical Business Overview Table 89. Huayang Medical Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Huayang Medical Medical Polyglycolic Acid (PGA) Product Portfolio Table 91. Huayang Medical Recent Development Table 92. Danhua Technology Company Information Table 93. Danhua Technology Business Overview Table 94. Danhua Technology Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Danhua Technology Medical Polyglycolic Acid (PGA) Product Portfolio Table 96. Danhua Technology Recent Development Table 97. Shenzhen Polymtek Biomaterial Company Information Table 98. Shenzhen Polymtek Biomaterial Business Overview Table 99. Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Product Portfolio Table 101. Shenzhen Polymtek Biomaterial Recent Development Table 102. Kureha Company Information Table 103. Kureha Business Overview Table 104. Kureha Medical Polyglycolic Acid (PGA) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Kureha Medical Polyglycolic Acid (PGA) Product Portfolio Table 106. Kureha Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Medical Polyglycolic Acid (PGA) Distributors List Table 110. Medical Polyglycolic Acid (PGA) Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Medical Polyglycolic Acid (PGA) Product Image Figure 2. Global Medical Polyglycolic Acid (PGA) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Polyglycolic Acid (PGA) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Polyglycolic Acid (PGA) Sales (2021-2032) & (Tons) Figure 5. Global Medical Polyglycolic Acid (PGA) Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Medical Polyglycolic Acid (PGA) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Copolymer Image Figure 10. Homopolymer Image Figure 11. Block Copolymers Image Figure 12. Global Medical Polyglycolic Acid (PGA) Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Medical Polyglycolic Acid (PGA) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Type (2021-2032) Figure 15. Global Medical Polyglycolic Acid (PGA) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medical Polyglycolic Acid (PGA) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Type (2021-2032) Figure 18. Tissue Engineering Scaffold Image Figure 19. Medical Suture Image Figure 20. Drug Controlled Release Carrier Image Figure 21. Fracture Fixation Material Image Figure 22. Stitched Reinforcement Material Image Figure 23. Global Medical Polyglycolic Acid (PGA) Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Medical Polyglycolic Acid (PGA) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Application (2021-2032) Figure 26. Global Medical Polyglycolic Acid (PGA) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Medical Polyglycolic Acid (PGA) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Application (2021-2032) Figure 29. Global Medical Polyglycolic Acid (PGA) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Medical Polyglycolic Acid (PGA) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Medical Polyglycolic Acid (PGA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Medical Polyglycolic Acid (PGA) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Medical Polyglycolic Acid (PGA) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Medical Polyglycolic Acid (PGA) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Medical Polyglycolic Acid (PGA) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Medical Polyglycolic Acid (PGA) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Medical Polyglycolic Acid (PGA) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Medical Polyglycolic Acid (PGA) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Medical Polyglycolic Acid (PGA) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Medical Polyglycolic Acid (PGA) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Medical Polyglycolic Acid (PGA) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Medical Polyglycolic Acid (PGA) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Medical Polyglycolic Acid (PGA) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Medical Polyglycolic Acid (PGA) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Copolymer
  • Homopolymer
  • Block Copolymers
Applications
  • Tissue Engineering Scaffold
  • Medical Suture
  • Drug Controlled Release Carrier
  • Fracture Fixation Material
  • Stitched Reinforcement Material
Companies covered
  • Sinopec
  • Yulin Energy Group
  • Evonik
  • Shanghai Pujing Chemical
  • Huayang Medical
  • Danhua Technology
  • Shenzhen Polymtek Biomaterial
  • Kureha

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Polyglycolic Acid (PGA) Sales Value (2021-2032)
  4. 1.2.2 Global Medical Polyglycolic Acid (PGA) Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Polyglycolic Acid (PGA) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Polyglycolic Acid (PGA) Market Dynamics
  1. 2.1 Medical Polyglycolic Acid (PGA) Industry Trends
  2. 2.2 Medical Polyglycolic Acid (PGA) Industry Drivers
  3. 2.3 Medical Polyglycolic Acid (PGA) Industry Opportunities and Challenges
  4. 2.4 Medical Polyglycolic Acid (PGA) Industry Restraints
3 Medical Polyglycolic Acid (PGA) Market by Company
  1. 3.1 Global Medical Polyglycolic Acid (PGA) Company Revenue Ranking in 2025
  2. 3.2 Global Medical Polyglycolic Acid (PGA) Revenue by Company (2021-2026)
  3. 3.3 Global Medical Polyglycolic Acid (PGA) Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Polyglycolic Acid (PGA) Average Price by Company (2021-2026)
  5. 3.5 Global Medical Polyglycolic Acid (PGA) Company Ranking (2024-2026)
  6. 3.6 Global Medical Polyglycolic Acid (PGA) Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Polyglycolic Acid (PGA) Company Product Type and Application
  8. 3.8 Global Medical Polyglycolic Acid (PGA) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Polyglycolic Acid (PGA) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Polyglycolic Acid (PGA) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Polyglycolic Acid (PGA) Market by Type
  1. 4.1 Medical Polyglycolic Acid (PGA) Type Introduction
  2. 4.1.1 Copolymer
  3. 4.1.2 Homopolymer
  4. 4.1.3 Block Copolymers
  5. 4.2 Global Medical Polyglycolic Acid (PGA) Sales Volume by Type
  6. 4.2.1 Global Medical Polyglycolic Acid (PGA) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Polyglycolic Acid (PGA) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Medical Polyglycolic Acid (PGA) Sales Value by Type
  10. 4.3.1 Global Medical Polyglycolic Acid (PGA) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Medical Polyglycolic Acid (PGA) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Medical Polyglycolic Acid (PGA) Sales Value Share by Type (2021-2032)
5 Medical Polyglycolic Acid (PGA) Market by Application
  1. 5.1 Medical Polyglycolic Acid (PGA) Application Introduction
  2. 5.1.1 Tissue Engineering Scaffold
  3. 5.1.2 Medical Suture
  4. 5.1.3 Drug Controlled Release Carrier
  5. 5.1.4 Fracture Fixation Material
  6. 5.1.5 Stitched Reinforcement Material
  7. 5.2 Global Medical Polyglycolic Acid (PGA) Sales Volume by Application
  8. 5.2.1 Global Medical Polyglycolic Acid (PGA) Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Medical Polyglycolic Acid (PGA) Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Medical Polyglycolic Acid (PGA) Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Medical Polyglycolic Acid (PGA) Sales Value by Application
  12. 5.3.1 Global Medical Polyglycolic Acid (PGA) Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Medical Polyglycolic Acid (PGA) Sales Value by Application (2021-2032)
  14. 5.3.3 Global Medical Polyglycolic Acid (PGA) Sales Value Share by Application (2021-2032)
6 Medical Polyglycolic Acid (PGA) Regional Sales and Value Analysis
  1. 6.1 Global Medical Polyglycolic Acid (PGA) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Polyglycolic Acid (PGA) Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Polyglycolic Acid (PGA) Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Polyglycolic Acid (PGA) Sales by Region (2027-2032)
  5. 6.3 Global Medical Polyglycolic Acid (PGA) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Polyglycolic Acid (PGA) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Polyglycolic Acid (PGA) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Polyglycolic Acid (PGA) Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Polyglycolic Acid (PGA) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Polyglycolic Acid (PGA) Sales Value (2021-2032)
  12. 6.6.2 North America Medical Polyglycolic Acid (PGA) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Polyglycolic Acid (PGA) Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Polyglycolic Acid (PGA) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Polyglycolic Acid (PGA) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Polyglycolic Acid (PGA) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Polyglycolic Acid (PGA) Sales Value (2021-2032)
  21. 6.9.2 South America Medical Polyglycolic Acid (PGA) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Polyglycolic Acid (PGA) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Polyglycolic Acid (PGA) Sales Value Share by Country, 2025 VS 2032
7 Medical Polyglycolic Acid (PGA) Country-level Sales and Value Analysis
  1. 7.1 Global Medical Polyglycolic Acid (PGA) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Polyglycolic Acid (PGA) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Polyglycolic Acid (PGA) Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Polyglycolic Acid (PGA) Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Polyglycolic Acid (PGA) Sales by Country (2027-2032)
  6. 7.4 Global Medical Polyglycolic Acid (PGA) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Polyglycolic Acid (PGA) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Polyglycolic Acid (PGA) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Polyglycolic Acid (PGA) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Polyglycolic Acid (PGA) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Polyglycolic Acid (PGA) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sinopec
  2. 8.1.1 Sinopec Company Information
  3. 8.1.2 Sinopec Business Overview
  4. 8.1.3 Sinopec Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sinopec Medical Polyglycolic Acid (PGA) Product Portfolio
  6. 8.1.5 Sinopec Recent Developments
  7. 8.2 Yulin Energy Group
  8. 8.2.1 Yulin Energy Group Company Information
  9. 8.2.2 Yulin Energy Group Business Overview
  10. 8.2.3 Yulin Energy Group Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yulin Energy Group Medical Polyglycolic Acid (PGA) Product Portfolio
  12. 8.2.5 Yulin Energy Group Recent Developments
  13. 8.3 Evonik
  14. 8.3.1 Evonik Company Information
  15. 8.3.2 Evonik Business Overview
  16. 8.3.3 Evonik Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Medical Polyglycolic Acid (PGA) Product Portfolio
  18. 8.3.5 Evonik Recent Developments
  19. 8.4 Shanghai Pujing Chemical
  20. 8.4.1 Shanghai Pujing Chemical Company Information
  21. 8.4.2 Shanghai Pujing Chemical Business Overview
  22. 8.4.3 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Product Portfolio
  24. 8.4.5 Shanghai Pujing Chemical Recent Developments
  25. 8.5 Huayang Medical
  26. 8.5.1 Huayang Medical Company Information
  27. 8.5.2 Huayang Medical Business Overview
  28. 8.5.3 Huayang Medical Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Huayang Medical Medical Polyglycolic Acid (PGA) Product Portfolio
  30. 8.5.5 Huayang Medical Recent Developments
  31. 8.6 Danhua Technology
  32. 8.6.1 Danhua Technology Company Information
  33. 8.6.2 Danhua Technology Business Overview
  34. 8.6.3 Danhua Technology Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Danhua Technology Medical Polyglycolic Acid (PGA) Product Portfolio
  36. 8.6.5 Danhua Technology Recent Developments
  37. 8.7 Shenzhen Polymtek Biomaterial
  38. 8.7.1 Shenzhen Polymtek Biomaterial Company Information
  39. 8.7.2 Shenzhen Polymtek Biomaterial Business Overview
  40. 8.7.3 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Product Portfolio
  42. 8.7.5 Shenzhen Polymtek Biomaterial Recent Developments
  43. 8.8 Kureha
  44. 8.8.1 Kureha Company Information
  45. 8.8.2 Kureha Business Overview
  46. 8.8.3 Kureha Medical Polyglycolic Acid (PGA) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kureha Medical Polyglycolic Acid (PGA) Product Portfolio
  48. 8.8.5 Kureha Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Polyglycolic Acid (PGA) Value Chain Analysis
  2. 9.1.1 Medical Polyglycolic Acid (PGA) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Polyglycolic Acid (PGA) Sales Mode & Process
  6. 9.2 Medical Polyglycolic Acid (PGA) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Polyglycolic Acid (PGA) Distributors
  9. 9.2.3 Medical Polyglycolic Acid (PGA) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst